Benzinga's Volume Movers

shares climbed 65.89 percent to $29.86. The volume of Aerie Pharmaceuticals shares traded was 4798 percent higher than normal. Aerie Pharmaceuticals announced that Rhopressa Phase 3 trial has achieved primary endpoint.

surged 15.31 percent to $32.91. The volume of Cablevision Systems shares traded 3317 percent higher than normal. Altice SA agreed to buy Cablevision Systems for around $17.7 billion.

shares moved up 9.74 percent to $11.83. The volume of Lakeland Industries traded was 1199 percent higher than normal. Lakeland reported Q2 earnings of $0.28 per share on sales of $29.5 million.

shares rose 7.93 percent to $52.66. The volume of Intra-Cellular Therapies shares traded was 514 percent higher than normal. On Wednesday, Intra-Cellular Therapies announced positive top line results for ITI-007 first Phase 3 trial.